Ongoing research into pharmacological agents or gene therapies targeting this pathway could translate into novel neuroprotective interventions in stroke management
Currently, two ongoing clinical trials are investigating the role of GLP-1 RAs in IBD management, that would lead to further knowledge: a French study (ID NCT05196958) evaluating the safety and efficacy of GLP-1 RAs in treatment of DM2 in overweight IBD patients (115), and an American study (ID NCT06774079) comparing the efficacy of GLP-1 RAs tirzepatide versus diet in CD patients (116)
For a broader look at what the first weeks of therapy feel like, read Provns guide on what to expect during your first month on GLP-1 therapy
CAEs were then filtered and grouped into the reason for use in the following groups: T2DM, weight management (WM), and T2DM+WM
A total of 1030% of AD patients meet the diagnostic requirements for severe depression (Mann et al
E.Zimmermann-KogadeevaM.PatilK